A Case Report of concurrent SARS-CoV-2 infection and multi-drug-resistant tuberculous meningitis

1 Galimi, R., Extrapulmonary Tuberculosis: Tuberculous Meningitis New Developments. Eur. Rev. Med. Pharmacol. Sci. 2011, 15, 4, 365-386. https://doi.org/10.1155/2011/798764 Search in Google Scholar

2 Cherian, A., Chellappan, K., Iype, T., et al. Neurotuberculosis: An Update. Acta Neurol. Belg. 2021, 121, 1, 11-21. Search in Google Scholar

3 Verdon, R., Chevret, S., Laissy, J., et al. Tuberculous Meningitis in Adults: A Review of 48 Cases. Clin. Infect. Dis. 1996, 22, 6, 982-988. Search in Google Scholar

4 Bidstrup, C., Andersen, P. H., Skinhøj, P., et al. Tuberculous Meningitis in a Country with a Low Incidence of Tuberculosis: Still a Serious Disease and a Diagnostic Challenge. Scand. J. Infect. Dis. 2002, 34,11, 811-814. Search in Google Scholar

5 Grace, E. M., Edward, D. C., Tuberculous Meningitis: Diagnosis and Treatment Overview. Tuberculosis Res. Treat. 2011, Volume 2011, Article ID 798764. https://doi.org/10.1155/2011/798764 Search in Google Scholar

6 Rich, A. R., McCormick, H. A. The Pathogenesis of Tuberculous Meningitis. Bull. Johns Hopkins Hosp. 1933, 52, 5-37. Search in Google Scholar

7 Farinha, N. J., Razali, K. A., Holzel, H. et al. Tuberculosis of the Central Nervous System in Children: A 20-Year Survey. J. Infect. 2000, 41, 1, 61-68. Search in Google Scholar

8 Eliot, H., Lauren D., Jijee A. Bacterial meningitis and COVID-19: a complex patient journey. BMJ Case Rep. 2021;14(3):e239533 DOI: 10.1136/bcr-2020-239533 Search in Google Scholar

9 Mittal, N., Bansal, P., Multidrug Resistant Extrapulmonary Tuberculosis – Three Case Reports and Review of Literature. Intern. Med. 2014, 2, 2. https://doi.org/10.7243/2052-6954-2-2 Search in Google Scholar

10 World Health Organization. WHO Consolidated Guidelines on Drug-Resistant Tuberculosis Treatment. World Health Organization, Geneva, 2019. Search in Google Scholar

11 Tamar W., Nicole H., The neurological symptoms of COVID-19: a systematic overview of systematic comparison with other neurological condition implications for healthcare services. The Adv Chronic Dis. 2021 Jan 28:12:2040622 DOI: 10.1177/2040622320976979 Search in Google Scholar

12 Rahman, A., Sahrin, M., Afrin, S. et al. Comparison of Xpert MTB/RIF Assay and GenoType MTBDRplus DNA Probes for Detection of Mutations Associated with Rifampicin Resistance in Mycobacterium Tuberculosis. PLoS ONE 2016, 11, 4, e0152694. https://doi.org/10.1371/journal.pone.0152694 Search in Google Scholar

13 Cornelia, C., Svetlana, H., Mariana, S., Maria, M. Meningita Tuberculoasa – Dificultati de Diagnostic si Particularitati Evolutive. Search in Google Scholar

14 Henry, M., Holzman, R. S. Tuberculosis of the Brain, Meninges, and Spinal Cord. In Tuberculosis; Rom, W. N.; Garay, S. M., et al., Eds.; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2nd edition, 2004; pp. 445-464. Search in Google Scholar

15 Iseman, M. D. Clinician’s Guide to Tuberculosis. Lippincott Williams & Wilkins, Baltimore, MD, USA, 1999. Search in Google Scholar

16 Kennedy, D. H., Fallon, R. J. Tuberculous Meningitis. JAMA 1979, 241, 3, 264-268. Search in Google Scholar

17 Haddaoui, H., Mrabet, F. Z., Aharmim, M. et al. Tuberculose Extrapulmonaire Multi Résistante: À Propos de 7 Cas. Pan Afr. Med. J. 2019, p. 32. Search in Google Scholar

18 Tiresse, N., Oucharqui, S., Benai, E., et al. The Occurrence of Multidrug-Resistant Tuberculous Retropharyngeal Abscess in an Immunocompetent Patient: A Case Report. Search in Google Scholar

19 Thwaites, G. E., Bhavnani, S. M., Chau, T. T. H., et al. Randomized Pharmacokinetic and Pharmacodynamic Comparison of Fluoroquinolones for Tuberculous Meningitis. Antimicrob. Agents Chemother. 2011, 55, 7, 3244-3253. Search in Google Scholar

20 Verdon, R., Chevret, S., Laissy, J. P., et al. Tuberculous Meningitis in Adults: A Review of 48 Cases. Clin. Infect. Dis. 1996, 22, 6, 982-988. Search in Google Scholar